Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RPRXthis companyRoyalty Pharma plc	$68.15	16.58×	2.58×	7.02×	15.3×	-70.4%	100.0%	65.6%	32.4%	11.9%	8.9%	14.9%	1.38×	5.09×	5.07×	0.97×	2.3%	6	2.39	3	B
RGLDRoyal Gold, Inc.	$276.73	33.18×	2.16×	14.98×	20.87×	-34.1%	69.3%	64.5%	45.2%	6.5%	5.8%	-3.0%	0.13×	0.95×	28.4×	3.12×	0.8%	4	7.46	4	A-
Peer median	—	33.18×	2.16×	14.98×	20.87×	-34.1%	69.3%	64.5%	45.2%	6.5%	5.8%	-3.0%	0.13×	0.95×	28.4×	3.12×	0.8%	4	7.46	4	—